- NZD/USD registers a three-day winning streak.
- Risk-tone remains positive amid hopes of further stimulus from the US.
- US data, coronavirus headlines and the COVID-19 Bill expectations in the spotlight.
With New Zealand’s February month trade data coming in better than previous, backed by the RBNZ’s QE proposal, NZD/USD extends the recovery gains to 0.5840 amid the early Wednesday morning in Asia.
New Zealand’s February month Trade balance recovered from $-3.87B previous to $-3.26B. Details suggest the mixed moves by the Imports and the Exports data as the former weakened from $5.073B to $4.33B while the later rose to $4.92B versus $4.73B earlier readouts.
The pair recently took clues from the RBNZ’s proposal of 250 million New Zealand dollar worth of government bond-buying as a part of its first tranche of the Quantitative Easing (QE). The move is a part of the central bank’s earlier pledged $30 billion of New Zealand Government Bond (NZGB) purchase with a range of maturities across the yield curve over the next 12 months.
Also affecting the quote’s latest moves were optimism surrounding the US COVID-19 Bill, the Fed’s unlimited QE and the reduction in Italy’s death toll. The trifecta impact boosted the market’s risk tone together with the US 10-year treasury yields and equities.
Markets are likely to await further details on how much and when the US aid package will be announced. Also on the traders’ radar will be the coronavirus headlines as well as the US data concerning the February month Durable Goods Orders, expected -0.8% versus -0.2%.
While 10-day SMA, currently near 0.5870, acts as the immediate upside barrier for the pair, last Wednesday’s top near 0.5970 and 0.6000 mark could restrict its further recoveries. On the downside, 0.5740 and 0.5600 should be watched carefully during the quote’s fresh declines.
Additional important levels
|Today last price||0.5838|
|Today Daily Change||120 pips|
|Today Daily Change %||2.10%|
|Today daily open||0.5718|
|Previous Daily High||0.5739|
|Previous Daily Low||0.5589|
|Previous Weekly High||0.6151|
|Previous Weekly Low||0.547|
|Previous Monthly High||0.6504|
|Previous Monthly Low||0.6192|
|Daily Fibonacci 38.2%||0.5681|
|Daily Fibonacci 61.8%||0.5646|
|Daily Pivot Point S1||0.5625|
|Daily Pivot Point S2||0.5532|
|Daily Pivot Point S3||0.5475|
|Daily Pivot Point R1||0.5775|
|Daily Pivot Point R2||0.5832|
|Daily Pivot Point R3||0.5925|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.